Although it is not uncommon for individuals with relapsing multiple sclerosis (MS) to experience progression independent of relapse activity (PIRA) after a first demyelinating event, research suggests that PIRA and the timing of it after first demyelinating event portends an unfavorable long-term prognosis. Explore this insightful study to learn about the critical role of PIRA in MS prognosis and how it can inform more effective management strategies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
56 of 56 courses listed here are free.
Collected from the provider’s public pages
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedApr 21, 2025
-
Last day to claim creditApr 1, 2027 6 months left
-
Society of Hospital Medicine The Beans and the Brain in Serious Illness: Getting the Tunes Right in Foretelling Prognosis and Symptom management – On Demand 2026 (2026-2029)
-
University of California, San Francisco GeriPal Podcast: Prognosis Superspecial
-
CAPC +1 CAPC: Communicating Prognosis to Patients and Caregivers
